MXPA05003283A - Composicion de polimero y formas de dosis que comprenden la misma. - Google Patents

Composicion de polimero y formas de dosis que comprenden la misma.

Info

Publication number
MXPA05003283A
MXPA05003283A MXPA05003283A MXPA05003283A MXPA05003283A MX PA05003283 A MXPA05003283 A MX PA05003283A MX PA05003283 A MXPA05003283 A MX PA05003283A MX PA05003283 A MXPA05003283 A MX PA05003283A MX PA05003283 A MXPA05003283 A MX PA05003283A
Authority
MX
Mexico
Prior art keywords
same
dosage forms
polymer composition
dosage form
composition
Prior art date
Application number
MXPA05003283A
Other languages
English (en)
Spanish (es)
Inventor
Jen-Chi Chen
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/031062 external-priority patent/WO2003026626A2/en
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Priority claimed from PCT/US2003/008960 external-priority patent/WO2004028514A1/en
Publication of MXPA05003283A publication Critical patent/MXPA05003283A/es

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA05003283A 2002-09-28 2003-03-21 Composicion de polimero y formas de dosis que comprenden la misma. MXPA05003283A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PCT/US2002/031062 WO2003026626A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031163 WO2003026627A1 (en) 2001-09-28 2002-09-28 Composite dosage forms
PCT/US2002/031024 WO2003026625A1 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031117 WO2003026629A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031129 WO2003026630A1 (en) 2001-09-28 2002-09-28 Dosage forms having an inner core and outer shell with different shapes
PCT/US2003/008960 WO2004028514A1 (en) 2002-09-28 2003-03-21 Polymer composition and dosage forms comprising the same

Publications (1)

Publication Number Publication Date
MXPA05003283A true MXPA05003283A (es) 2005-11-23

Family

ID=34271652

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05003283A MXPA05003283A (es) 2002-09-28 2003-03-21 Composicion de polimero y formas de dosis que comprenden la misma.

Country Status (8)

Country Link
JP (3) JP2006517182A (pt)
CN (3) CN1684671A (pt)
AT (1) ATE444739T1 (pt)
AU (4) AU2003218359A1 (pt)
BR (5) BR0314787A (pt)
CA (3) CA2500313C (pt)
DE (2) DE60329614D1 (pt)
MX (1) MXPA05003283A (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2470463C (en) 2004-06-09 2012-09-18 Lornamead Brands, Inc. Tooth whitening products and methods of making the same
SA07280459B1 (ar) * 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
WO2009153635A1 (en) * 2008-06-19 2009-12-23 University Of Witwatersrand, Johannesburg A chronotherapeutic pharmaceutical dosage form
EP2550960A4 (en) * 2010-03-23 2013-08-28 Lintec Corp SOLID PREPARATION
WO2013009701A2 (en) * 2011-07-08 2013-01-17 The University Of North Carolina At Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
BR112014019526B8 (pt) * 2012-02-07 2022-08-30 Chenango Zero Llc Forma de dosagem de liberação rápida e seu método de produção
TW201400146A (zh) * 2012-06-05 2014-01-01 Takeda Pharmaceutical 有核錠
RU2017106028A (ru) * 2014-09-19 2018-10-22 Дзе Проктер Энд Гэмбл Компани Лекарственная форма фенилэфрина с пульсирующим высвобождением
JP2021516697A (ja) 2017-12-29 2021-07-08 ラクソン メディカル アーゲーＬａｘｘｏｎ Ｍｅｄｉｃａｌ ＡＧ 薬物送達システム
KR20240039030A (ko) * 2021-07-30 2024-03-26 에벡시아 테라퓨틱스 아이엔씨. 5-하이드록시트립토판 위체류성 투여 형태
CN115295864B (zh) * 2021-11-09 2023-08-11 深圳市德方创域新能源科技有限公司 正极补锂添加剂及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07507564A (ja) * 1992-09-30 1995-08-24 ファイザー・インク． コア及び厚さが一定でないコーティングを含有する物品
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
AU2001250646A1 (en) * 2000-04-17 2001-10-30 Yamanouchi Pharmaceutical Co..Ltd. Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof
MXPA03007092A (es) * 2001-02-13 2003-11-18 Astrazeneca Ab Nueva formulacion de liberacion modificada.

Also Published As

Publication number Publication date
ATE444739T1 (de) 2009-10-15
AU2003218359A1 (en) 2004-04-19
CN1700908A (zh) 2005-11-23
JP2006517182A (ja) 2006-07-20
BR0314777A (pt) 2005-07-26
DE60335270D1 (de) 2011-01-20
CA2500313C (en) 2011-06-07
DE60329614D1 (de) 2009-11-19
BR0314804A (pt) 2005-08-02
AU2003220466A1 (en) 2004-04-19
CA2500311A1 (en) 2004-04-08
JP2006517514A (ja) 2006-07-27
AU2003225944A1 (en) 2004-04-19
JP2006517183A (ja) 2006-07-20
CA2500313A1 (en) 2004-04-08
CN1684671A (zh) 2005-10-19
BR0314547A (pt) 2005-08-09
BR0314787A (pt) 2005-07-26
BR0314781A (pt) 2005-07-26
CA2500312A1 (en) 2004-04-08
CN1700907A (zh) 2005-11-23
AU2003220472A1 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
GB0614353D0 (en) Oral compositions, their preparation and use
WO2003090726A3 (en) Chewable soft capsule
CA2331264A1 (en) Compositions and methods for drug delivery
CA2303498A1 (en) Dioxocyclopentyl hydroxamic acids
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
KR880701544A (ko) 이온화 가능한 의약 제제용 용해 시스템
MXPA05003283A (es) Composicion de polimero y formas de dosis que comprenden la misma.
DE502006009024D1 (de) Fettsäureanhydride enthaltende dispersionspulver
BR0007589A (pt) Inibidores da proliferação de células
DE69906269D1 (de) Wässriges verfahren zur herstellung fester paroxetin-dispersionen
CA2444203A1 (en) Pet food composition containing semi-refined gelling agent
GB0123572D0 (en) Polymer compositions
BR0015197A (pt) Copolìmero vinìlico, e, composição
GB2443793B (en) Product, method of manufacture and use
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
NO20050247L (no) Lavmolekylaert oversulfatert polysakkarid
TW200630121A (en) Immediate release film coating
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
ATE268181T1 (de) Pharmazeutische zubereitungen enthaltend alginate
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
BR0212195A (pt) Composições contendo pectina e ácido ascórbico
DE50009804D1 (de) Vernetzerfreie zubereitungen
WO2004030469A3 (en) Gelling composition